Access cutting-edge chronic obstructive pulmonary disease treatment through this clinical trial at a research site in Burlington. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Burlington location
Preparing your pre-screening questions…
Access chronic obstructive pulmonary disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic obstructive pulmonary disease treatment provided free
Check if you qualify for this chronic obstructive pulmonary disease clinical trial in Burlington, VT
No-Cost Study Care
Local to Burlington
Convenient for VT residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This proposed project will be a single arm, non-masked study. Participants who are actively smoking with a diagnosis of a new lung nodule, either confirmed or suspicious for lung cancer, with a plan for lung cancer treatment with or without surgical resection will be recruited from the University of Vermont Medical Center (UVMMC)pulmonary, cardiothoracic surgery, and Lung Multidisciplinary Clinic (LMDC). All patients will be enrolled in prehab and offered smoking cessation therapy. The acceptability and feasibility of this intervention will be measured by percent enrollment in study, attendance, barriers to completion, and monitoring of adverse events. The effect of prehab will be measured by traditional metrics, including fitness, respiratory symptoms, and depression scale. Research outcomes will be measured by smoking habits, anxiety, and surgical complications. Investigators estimate that 20 participants over a two-year period will be sufficient to measure the safety and feasibility of this study. Investigators aim to enroll, on average, 2 participants per month in order to complete this study in a timely fashion. Participants will be enrolled in prehab on a rolling basis, as to not delay surgical timeline.
Sponsor: University of Vermont
Yes, this clinical trial (NCT06432972) has an active research site in Burlington, VT that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic obstructive pulmonary disease treatment options in Burlington, VT, this clinical trial (NCT06432972) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Burlington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic obstructive pulmonary disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic obstructive pulmonary disease clinical trials near you to find additional studies recruiting in your area.
See all ulcerative colitis clinical trials recruiting in Burlington — not just this study.
Browse Ulcerative Colitis Trials in Burlington →